Dr Abdul Mannan: The Mentzer Index Remains a Cornerstone Screening Tool in Haematology
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
“The Mentzer Index: A Valuable yet Imperfect Tool
The Mentzer Index remains a cornerstone screening tool in haematology.
It offers immediate differentiation between iron deficiency anaemia and β-thalassaemia trait using routine FBC parameters—no additional cost, no delay.
Its elegance lies in its simplicity: MCV divided by red cell count. However, limitations are critical: grey zone cases (MI 11–15), dual pathology, and α-thalassaemia confound interpretation.
The index guides, not diagnoses—confirmatory ferritin and HbA₂ quantification remain mandatory. In resource-limited settings, it prioritises costly testing.
In high-resource settings, it prevents diagnostic delay. Never use in isolation; always integrate clinical context, ethnicity, and family history.
The Mentzer Index exemplifies evidence-based medicine: a simple calculation with profound clinical impact when used judiciously.”
Title: Mentzer Index — Evidence-Based Review
Authors: Dr Abdul Mannan FRCPath FCPS
Read full article here.
Stay informed with Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action